Given the urgent nature of the procedures within the trauma device market, the impact of the COVID-19 pandemic was less severe and the recovery was relatively fast for the Latin American trauma device market. However, the market has been affected by delays to nonurgent trauma cases and the use of alternative treatments for less serious cases, and more recent supply chain constraints experienced by major manufacturers have restricted expansion. The market will continue to be driven primarily by favorable demographics, improving reimbursement and site-of-service flexibility, improving physician training, and ongoing product innovation.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in Latin America from 2019 through 2031.
The trauma device market was quick to recover from the COVID-19 pandemic.
To what extent has the trauma market recovered from the effects of the COVID-19 pandemic?
When will each segment of the market return to levels seen prior to the pandemic?
Several manufacturers have recently expanded their product portfolios with the introduction of new devices or by acquiring companies with complementary products.
Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?
How are competitors expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share of the trauma device market?
Trauma procedures are increasingly performed in the outpatient setting.
How has COVID-19 impacted this trend?
How does the site of service affect the choice of trauma device used?
The Latin American trauma device market is projected to grow through 2031.
Which device segments are growing the fastest, and why?
Which anatomic segments contribute most strongly to overall procedure volumes?
Which devices do physicians prefer to use to treat these anatomies?
Which anatomic segments are seeing increased interest from competitors, and why?
How are procedural trends shifting due to improved technology and clinical data?
Which device segment is seeing declines, and what is contributing to this?
The expanding aging populations and growing middle class in Brazil and Colombia will drive overall market growth.
As the largest market in the Latin American region, to what extent will procedure volumes grow within the Brazilian market for trauma devices?
How will the Colombia market grow in comparison to Brazil and the rest of the Latin America region?
Strong competition between MNCs and domestic players will continue to place downward pricing pressures in the Latin American trauma device market.
Which local competitors have been able to capture notable shares within the Latin America trauma device space?
What are the key competitive strategies used by domestic competitors to remain competitive in the trauma market?
What other strategies are MNCs using to remain competitive in the face of strong pricing pressures?
How will purchasing preferences in this region evolve during the forecast period?
Rising awareness among patients complemented by increased surgical training will drive demand for premium-priced devices; however, uptake of these products will be somewhat restricted by hospital budget constraints.
Which type of premium devices will continue to display revenue growth despite these pressures?
Which countries will face the greatest pricing pressures?